KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cigna (CI) Other Non Operating Income (2018 - 2025)

Cigna (CI) has disclosed Other Non Operating Income for 8 consecutive years, with -$362.0 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income changed 0.0% to -$362.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Dec 2025, up 1.88% year-over-year, with the annual reading at -$1.4 billion for FY2025, 1.88% up from the prior year.
  • Other Non Operating Income hit -$362.0 million in Q4 2025 for Cigna, down from -$347.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $774.0 million in Q4 2021 to a low of -$376.0 million in Q3 2024.
  • Historically, Other Non Operating Income has averaged -$282.9 million across 5 years, with a median of -$342.0 million in 2025.
  • Biggest YoY gain for Other Non Operating Income was 329.67% in 2021; the steepest drop was 2028.57% in 2021.
  • Year by year, Other Non Operating Income stood at $774.0 million in 2021, then tumbled by 141.86% to -$324.0 million in 2022, then dropped by 11.11% to -$360.0 million in 2023, then decreased by 0.56% to -$362.0 million in 2024, then changed by 0.0% to -$362.0 million in 2025.
  • Business Quant data shows Other Non Operating Income for CI at -$362.0 million in Q4 2025, -$347.0 million in Q3 2025, and -$337.0 million in Q2 2025.